SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-013854
Filing Date
2022-05-16
Accepted
2022-05-16 16:29:31
Documents
81
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1011780
2 ex31-1.htm EX-31.1 11969
3 ex31-2.htm EX-31.2 12031
4 ex32-1.htm EX-32.1 7048
5 ex32-2.htm EX-32.2 7234
  Complete submission text file 0001493152-22-013854.txt   6332300

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vynt-20220331.xsd EX-101.SCH 56117
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vynt-20220331_cal.xml EX-101.CAL 101327
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vynt-20220331_def.xml EX-101.DEF 283147
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vynt-20220331_lab.xml EX-101.LAB 510003
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vynt-20220331_pre.xml EX-101.PRE 399594
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 810109
Mailing Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002
Business Address 2370 STATE ROUTE 70 WEST SUITE 310 CHERRY HILL, NJ 08002 201.528.9200
Vyant Bio, Inc. (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35817 | Film No.: 22929702
SIC: 8071 Services-Medical Laboratories